Poland, Sweden and Belgium choose not to vaccinate elderly people with the vaccine of the British-Swedish pharmaceutical AstraZeneca and the University of Oxford. This is also recommended in other European countries because there is too little knowledge of the efficacy in seniors.
Belgium and Sweden do not provisionally administer the drug to over 65 people over. Poland only vaccinates adults up to 60 years of age. The countries follow the recommendations of medical experts. Sweden, among others, is looking forward to a large American study which may later clarify the effectiveness of the elderly.
The European Medicines Agency (EMA) approved it on Friday for everyone over 18 years of age, but indicated that there is not enough data to assess how well it works for people over 55. However, the watchdog expects it to provide protection to the elderly.
According to the Swedish health authorities, other EU countries, including Germany, have already decided to use other vaccines for seniors. The French regulator gave the green light to the use of the Astrazeneca vaccine on Tuesday, but advised not to administer it to people over 65 years of age.
In Austria and Germany, medical experts have recommended that the vaccine be administered only to people between 18 and 65 years of age. The Italian Medicines Agency recommends that the Astrazeneca vaccine be used only in residents under the age of 55, also because there is still uncertainty about its effectiveness in the elderly. In the Netherlands, the Health Council is still investigating which groups the vaccine is most suitable for.
This is the third corona vaccine approved in the European Union, following the more expensive vaccines from Moderna and Pfizer/BionTech. AstraZeneca has recently been under attack in the EU because it can deliver less than was agreed.